Application 216204
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | DIPHENHYDRAMINE CITRATE; IBUPROFEN | TABLET;ORAL | 38MG;200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216204-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | DIPHENHYDRAMINE CITRATE; IBUPROFEN | 38MG;200MG | TABLET / ORAL | 2022-05-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A216204-001 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 38MG;200MG | TABLET / ORAL | 2022-05-31 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMAZON BASIC CARE IBUPROFEN PM | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | Amazon.com Services LLC | 10ec6386-db13-a9dd-e063-6294a90a8261 | 2026-03-18 | Warnings | 216204 ANDA216204 |
| Ibuprofen and Diphenhydramine Citrate | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | Better Living Brands, LLC | fcfb044d-f6b9-5c43-e053-6394a90ac417 | 2024-10-29 | Warnings | 216204 ANDA216204 |
| Ibuprofen PM | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | KROGER COMPANY | 15e649c4-d75f-e8c1-e063-6294a90a7747 | 2024-07-26 | Warnings | 216204 ANDA216204 |
| Ibuprofen and Diphenhydramine Citrate | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | Aurohealth LLC | 21c1f5c5-19fa-4a59-bad3-ea85fd37471b | 2022-06-03 | Warnings | 216204 ANDA216204 58602-867 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 58602-867 | Ibuprofen and Diphenhydramine Citrate | Ibuprofen and Diphenhydramine Citrate | Aurohealth LLC | ANDA | Current |